Page 7 - 《中国药房》2021年16期
P. 7

·药事管理·

        我国省级抗菌药物临床应用分级管理目录分析                                                    Δ



              1*
                                                                                  1,3 #
        张 翕 ,杨瑶瑶 ,周 越 ,杜可欣 ,胡 琳 ,郑 波 ,管晓东 ,海沙尔江·吾守尔 ,史录文 (1.北京大学药
                        1
                                                        2
                                1
                                                                 1
                                        1
                                                                                            1,3
                                                1
        学院,北京 100191;2.北京大学第一医院临床药理研究所,北京 100191;3.北京大学医药管理国际研究中心,
        北京 100191)
        中图分类号 R969.3;R95         文献标志码 A           文章编号     1001-0408(2021)16-1921-05
        DOI  10.6039/j.issn.1001-0408.2021.16.01
        摘  要   目的:为科学监管和合理应用抗菌药物提供参考。方法:检索各省卫生行政部门官方网站、中国知网、公共搜索引擎等平
        台,收集并汇总2012年4月-2021年3月省级抗菌药物分级管理目录,对各省抗菌药物分级管理目录的差异和调整情况进行描述
        性统计分析。结果与结论:2012年4月以来,全国共有30个省份出台了抗菌药物分级管理目录,其中仅有10个省份对分级管理目
        录进行过调整。各省现行分级管理目录中,纳入抗菌药物品种数最多的是江苏(208种),最少的是新疆(101种);在各省目录包含
        的253种抗菌药物中,134种在各省分级管理目录中存在2种管理级别,19种在各省分级管理目录中存在3种管理级别。各省分级
        管理目录调整次数最多的10种抗菌药物主要涵盖硝咪唑类、β-内酰胺类复方制剂和喹诺酮类,且存在同种抗菌药物同时被调入或
        调出目录、上调或下调管理级别的现象。我国各省分级管理目录更新进度缓慢,且目录遴选药品数量和分级差异均较大,建议各
        省卫生行政部门应持续性地优化、完善抗菌药物分级管理目录,形成分级管理目录动态调整和省间证据共享的长效机制,从而进
        一步规范抗菌药物的临床应用,遏制细菌耐药。
        关键词 抗菌药物管理;分级管理目录;分析

        Analysis of Provincial Antibiotic Classification Management Lists in China
                  1              1          1          1       1            2               1
        ZHANG Xi ,YANG Yaoyao ,ZHOU Yue ,DU Kexin ,HU Lin ,ZHENG Bo ,GUAN Xiaodong ,Haishaerjiang·
                             1,3
                1,3
        Wushouer ,SHI Luwen (1. School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;2.
        Institute of Clinical Pharmacology,Peking University First Hospital,Beijing 100191,China;3. International
        Research Center for Medicinal Administration,Peking University,Beijing 100191,China)

        ABSTRACT   OBJECTIVE:To provide reference for scientific management and rational use of antibiotics. METHODS:Provincial
        antibiotic classification management lists were retrieved from official websites of provincial health administrative departments,
        CNKI and other search engines from Apr. 2012 to Mar. 2020. The difference and adjustment of those lists were analyzed
        descriptively. RESULTS & CONCLUSIONS: Since April 2012, 30 provinces released provincial antibiotic classification
        management lists,among which only 10 provinces updated the lists. In the provincial classification management lists,the list of
        Jiangsu included the most antibiotics(208 kinds),that of Xinjiang involved the least(101 kinds). Among the 253 antibiotics
        included in the provincial lists,134 antibiotics had two management levels,and 19 antibiotics had three management levels. The 10
        antibiotics with the most times of adjustment in the provincial lists mainly include nitimidazoles,β-lautam compound preparations
        and quinolones. There was the phenomenon that the same antibiotics were simultaneously included or withdrawn from the lists,and
        the grading management level was increased or decreased in the provincial adjustment. Provincial classification management lists
        updated slowly in China,and the quantity and classification of drugs selected in the list were quite different. It is suggested that
        provincial health administrative departments should continuously optimizeand improve classification management list of antibiotics,
        and form a long-term mechanism of dynamic adjustment of list and inter-provincial evidence sharing,so as to promote the rational
        clinical use of antibiotics,and curb bacterial resistance.
        KEYWORDS Antibiotic management;Classification management list;Analysis


            Δ 基金项目:国家自然科学基金资助项目(No.81861138048,                抗菌药物不合理应用引发的细菌耐药问题已成为
        No.81973294)
                                                           当今世界公共卫生体系面临的重大危机之一 。耐药菌
                                                                                                  [1]
           *硕士研究生。研究方向:药事管理。电话:010-82805019。
                                                           造成的感染可能会导致患者治疗费用增加、住院时间延
        E-mail:zhangxi2018@bjmu.edu.cn
           # 通信作者:助理研究员,博士。研究方向:公立医院改革与合理                  长、病情加重甚至死亡等严重结局                [2-6] 。为优化抗菌药
        用药。电话:010-82805019。E-mail:kaiser@bjmu.edu.cn       物的临床合理应用,遏制细菌耐药,2004 年我国卫生部

        中国药房    2021年第32卷第16期                                            China Pharmacy 2021 Vol. 32 No. 16  ·1921 ·
   2   3   4   5   6   7   8   9   10   11   12